We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Walgreens Boots Alliance (WBA - Free Report) closed the most recent trading day at $9.03, moving +0.22% from the previous trading session. The stock outperformed the S&P 500, which registered a daily gain of 0.02%. Elsewhere, the Dow gained 0.11%, while the tech-heavy Nasdaq lost 0.26%.
Heading into today, shares of the largest U.S. drugstore chain had lost 13.53% over the past month, lagging the Retail-Wholesale sector's gain of 3.9% and the S&P 500's gain of 2.99% in that time.
Investors will be eagerly watching for the performance of Walgreens Boots Alliance in its upcoming earnings disclosure. The company's earnings per share (EPS) are projected to be $0.40, reflecting a 39.39% decrease from the same quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $37.23 billion, up 1.43% from the year-ago period.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $1.53 per share and a revenue of $149.18 billion, signifying shifts of -46.88% and +1.03%, respectively, from the last year.
Investors should also pay attention to any latest changes in analyst estimates for Walgreens Boots Alliance. Recent revisions tend to reflect the latest near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the company's business and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 10.13% lower. Currently, Walgreens Boots Alliance is carrying a Zacks Rank of #3 (Hold).
In terms of valuation, Walgreens Boots Alliance is currently trading at a Forward P/E ratio of 5.91. For comparison, its industry has an average Forward P/E of 5.91, which means Walgreens Boots Alliance is trading at no noticeable deviation to the group.
Also, we should mention that WBA has a PEG ratio of 1.18. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Retail - Pharmacies and Drug Stores was holding an average PEG ratio of 0.94 at yesterday's closing price.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 227, which puts it in the bottom 10% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Walgreens Boots Alliance (WBA) Surpasses Market Returns: Some Facts Worth Knowing
Walgreens Boots Alliance (WBA - Free Report) closed the most recent trading day at $9.03, moving +0.22% from the previous trading session. The stock outperformed the S&P 500, which registered a daily gain of 0.02%. Elsewhere, the Dow gained 0.11%, while the tech-heavy Nasdaq lost 0.26%.
Heading into today, shares of the largest U.S. drugstore chain had lost 13.53% over the past month, lagging the Retail-Wholesale sector's gain of 3.9% and the S&P 500's gain of 2.99% in that time.
Investors will be eagerly watching for the performance of Walgreens Boots Alliance in its upcoming earnings disclosure. The company's earnings per share (EPS) are projected to be $0.40, reflecting a 39.39% decrease from the same quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $37.23 billion, up 1.43% from the year-ago period.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $1.53 per share and a revenue of $149.18 billion, signifying shifts of -46.88% and +1.03%, respectively, from the last year.
Investors should also pay attention to any latest changes in analyst estimates for Walgreens Boots Alliance. Recent revisions tend to reflect the latest near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the company's business and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 10.13% lower. Currently, Walgreens Boots Alliance is carrying a Zacks Rank of #3 (Hold).
In terms of valuation, Walgreens Boots Alliance is currently trading at a Forward P/E ratio of 5.91. For comparison, its industry has an average Forward P/E of 5.91, which means Walgreens Boots Alliance is trading at no noticeable deviation to the group.
Also, we should mention that WBA has a PEG ratio of 1.18. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Retail - Pharmacies and Drug Stores was holding an average PEG ratio of 0.94 at yesterday's closing price.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 227, which puts it in the bottom 10% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.